A Call to scrap Anthracyclines in Breast Cancer
SAN ANTONIO, Dec. 13 -- The anthracycline drugs -- long a mainstay of breast cancer chemotherapy -- only benefit a minority of women and should be mostly scrapped, a researcher said here.
Read full article: http://www.medpagetoday.com/Hematolo...Cancer/tb/7682 |
All times are GMT -7. The time now is 05:50 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021